Search

everythinglearnresearchcommunity

for

Search:↓

Where melanoma is on the body affects survival chances; melanomas on the back of the head are worse, while those on thighs and arms are less severe, and more sun exposure might improve survival.

The study concluded that scalp tumors show different patterns based on age, gender, and tumor thickness, and emphasized the importance of early detection and scalp examinations.

Tadalafil and Finasteride may help treat aggressive melanoma.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

BMI1 is essential for preventing hair greying and maintaining hair color.

Finasteride and dutasteride may lower melanoma risk, with teenage acne possibly indicating higher risk.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Living near more dermatologists and using certain cancer screening tests lowers the chance of being diagnosed with advanced skin cancer.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Four specific genes are linked to keloid formation and could be potential treatment targets.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Human skin responds to light with protective mechanisms, but more research is needed to understand these processes and their implications for health and therapy.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Cannabinoid receptor-1 signaling is essential for the survival and growth of human hair follicle stem cells.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Y27632 increases cell growth through EGFR signaling, not ROCK1/2.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Understanding how melanocyte stem cells work could lead to new treatments for hair graying and skin pigmentation disorders.

A new mRNA variant of the SCF gene in sheep skin produces a shorter, different protein.